Arbutus Biopharma Corporation Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q3 2024 | 3 | -$0.10 | -$0.08 | -$0.09 |
| Q4 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q1 2025 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q2 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 2 | -$0.09 | -$0.09 | -$0.09 |
Arbutus Biopharma Corporation Earnings Date And Information
Arbutus Biopharma Corporation last posted its earnings results on Thursday, August 1st, 2024. The company reported $-0.11 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.01. The company had revenue of 1.73 M for the quarter and had revenue of 18.14 M for the year. Arbutus Biopharma Corporation has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -9.66. Arbutus Biopharma Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Arbutus Biopharma Corporation Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2024 | Q2 2024 | -$0.11 | $1.77 M | $1.73 M | ||
| 05/02/2024 | Q1 2024 | -$0.10 | -$0.10 | 0 | $1.53 M | |
| 03/05/2024 | Q4 2023 | -$0.11 | $2.15 M | |||
| 11/07/2023 | Q3 2023 | -$0.12 | -$0.12 | 0 | $4.75 M | $4.66 M |
| 08/03/2023 | Q2 2023 | -$0.12 | -$0.10 | 0.02 | $6.18 M | $4.65 M |
| 05/04/2023 | Q1 2023 | -$0.14 | -$0.10 | 0.04 | $6.69 M | |
| 03/02/2023 | Q4 2022 | -$0.14 | -$0.15 | -0.01 | $6.25 M | |
| 11/09/2022 | Q3 2022 | -$0.12 | -$0.11 | 0.01 | $9.37 M | $5.95 M |
| 08/04/2022 | Q2 2022 | -$0.13 | -$0.10 | 0.03 | $6.77 M | $14.24 M |
| 05/05/2022 | Q1 2022 | -$0.13 | -$0.11 | 0.02 | $12.58 M | |
| 03/03/2022 | Q4 2021 | -$0.16 | -$0.21 | -0.05 | $3.21 M | |
| 11/04/2021 | Q3 2021 | -$0.24 | -$0.19 | 0.05 | $2.39 M | $3.34 M |
| 08/05/2021 | Q2 2021 | -$0.21 | -$0.20 | 0.01 | $2.12 M | $2.33 M |
| 05/05/2021 | Q1 2021 | -$0.22 | -$0.18 | 0.04 | $2.11 M | |
| 03/04/2021 | Q4 2020 | -$0.21 | -$0.18 | 0.03 | $2.39 M | |
| 11/05/2020 | Q3 2020 | -$0.20 | -$0.24 | -0.04 | $1.70 M | $1.52 M |
| 08/07/2020 | Q2 2020 | -$0.23 | -$0.20 | 0.03 | $1.80 M | $1.51 M |
| 05/11/2020 | Q1 2020 | -$0.32 | -$0.20 | 0.12 | $1.49 M | |
| 03/05/2020 | Q4 2019 | -$0.37 | -$0.36 | 0.01 | $1.62 M | |
| 11/06/2019 | Q3 2019 | -$0.11 | -$1.45 | -1.34 | $5.28 M | $3.06 M |
Arbutus Biopharma Corporation Earnings: Frequently Asked Questions
-
When is Arbutus Biopharma Corporation's earnings date?
Arbutus Biopharma Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
How can I listen to Arbutus Biopharma Corporation's earnings conference call?
The conference call for Arbutus Biopharma Corporation's latest earnings report can be listened to online.
-
How can I read Arbutus Biopharma Corporation's conference call transcript?
The conference call transcript for Arbutus Biopharma Corporation's latest earnings report can be read online.
-
How much revenue does Arbutus Biopharma Corporation generate each year?
Arbutus Biopharma Corporation (:ABUS) has a recorded annual revenue of $18.14 M.
-
How much profit does Arbutus Biopharma Corporation generate each year?
Arbutus Biopharma Corporation (:ABUS) has a recorded net income of $18.14 M. Arbutus Biopharma Corporation has generated $-0.44 earnings per share over the last four quarters.
-
What is Arbutus Biopharma Corporation's price-to-earnings ratio?
Arbutus Biopharma Corporation (:ABUS) has a price-to-earnings ratio of -9.66 and price/earnings-to-growth ratio is 4.15.
